
Ocean Biomedical, Inc.
NASDAQ:OCEA
Overview | Financials
Company Name | Ocean Biomedical, Inc. |
Symbol | OCEA |
Currency | USD |
Price | 0.011 |
Market Cap | 1,809,520 |
Dividend Yield | 0% |
52-week-range | 0.005 - 2.09 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Elizabeth Ng M.B.A. |
Website | http://www.oceanbiomedical.com |
An error occurred while fetching data.
About Ocean Biomedical, Inc.
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD